Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study-Reference-Cited by-同舟云学术

Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study

Published:2021-01 Issue: Volume:891 Page:173764
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Atsou Senade,Furlan Fiona,Duchemin Jérôme,Ellouze Syrine,Sourdeau Élise,Launois Amélie,Roussel-Robert Valérie,Stieltjes Natalie,Combe Sophie^ORCID,Fontenay Michaela,Curis Emmanuel^ORCID,Jourdi Georges

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. A longitudinal study of orthopaedic outcomes for severe factor-VIII deficient haemophiliacs. The Orthopaedic Outcome Study Group;Aledort;J. Intern. Med.,1994

2. Fitting linear mixed-effects models using lme4;Bates;J. Stat. Software,2015

3. Measurement of extended half-life recombinant factor IX products in clinical practice;Bowyer;Int. J. Lab. Hematol.,2019

4. International prophylaxis study group pharmacokinetics expert working group, implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia;Collins;Haemophilia,2011

5. Standardisation of thrombin generation test - which reference plasma for thrombin generation test?: an international multicenter study;Dargaud;Thromb. Res.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate;European Journal of Drug Metabolism and Pharmacokinetics;2024-02-17

2. Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics;Immunology;2023-12-23

3. Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases;Frontiers in Cardiovascular Medicine;2022-11-10